Mucosal shedding of human herpesvirus 8 in men
- PMID: 11070101
- DOI: 10.1056/NEJM200011093431904
Mucosal shedding of human herpesvirus 8 in men
Abstract
Background: Epidemiologic studies suggest that human herpesvirus 8 (HHV-8) is sexually transmitted among men who have sex with men; however, the mode of transmission is unclear.
Methods: To evaluate the patterns of shedding of HHV-8, we obtained mucosal-secretion samples from a cohort of HHV-8-seropositive men who had sex with men and had no clinical evidence of Kaposi's sarcoma. Quantitative polymerase-chain-reaction (PCR) assays, in situ PCR assays, and in situ RNA hybridization were used to identify potential sources of infectious HHV-8.
Results: We detected HHV-8 in at least one mucosal sample from 30 of 50 men who were seropositive for HHV-8 (60 percent). Overall, HHV-8 was detected in 30 percent of oropharyngeal samples, as compared with 1 percent of anal and genital samples (P<0.001). In 39 percent of the HHV-8-seropositive men, HHV-8 was detected in saliva on more than 35 percent of the consecutive days on which samples were obtained. The median log titer of HHV-8 from the oral cavity was approximately 2.5 times as high as the titer at all other sites. In situ hybridization studies indicated that HHV-8 DNA and messenger RNA were present in oral epithelial cells. Among 92 men who had sex with men and who were seronegative for the human immunodeficiency virus (HIV), a history of sex with a partner who had Kaposi's sarcoma, deep kissing with an HIV-positive partner, and the use of amyl nitrite capsules ("poppers") or inhaled nitrites were independent risk factors for infection with HHV-8.
Conclusions: Oral exposure to infectious saliva is a potential risk factor for the acquisition of HHV-8 among men who have sex with men. Hence, currently recommended safer sex practices may not protect against HHV-8 infection.
Comment in
-
Relation of rat brain acetylcholine levels to duration of self-stimulation and escape behavior.Pharmacol Biochem Behav. 1975 Jan-Feb;3(1):103-7. doi: 10.1016/0091-3057(75)90087-8. Pharmacol Biochem Behav. 1975. PMID: 1129345
-
The emergence of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).N Engl J Med. 2000 Nov 9;343(19):1411-3. doi: 10.1056/NEJM200011093431912. N Engl J Med. 2000. PMID: 11070109 No abstract available.
-
Mucosal shedding of human herpesvirus 8.N Engl J Med. 2001 Mar 1;344(9):690-1; author reply 691-2. doi: 10.1056/NEJM200103013440917. N Engl J Med. 2001. PMID: 11229344 No abstract available.
-
Mucosal shedding of human herpesvirus 8.N Engl J Med. 2001 Mar 1;344(9):691; author reply 691-2. N Engl J Med. 2001. PMID: 11229345 No abstract available.
-
Mucosal shedding of human herpesvirus 8.N Engl J Med. 2001 Mar 1;344(9):691; author reply 691-2. N Engl J Med. 2001. PMID: 11229346 No abstract available.
Similar articles
-
Sexual transmission and the natural history of human herpesvirus 8 infection.N Engl J Med. 1998 Apr 2;338(14):948-54. doi: 10.1056/NEJM199804023381403. N Engl J Med. 1998. PMID: 9521982
-
Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: implications for transmission.J Infect Dis. 2004 Jun 15;189(12):2260-70. doi: 10.1086/421119. Epub 2004 May 25. J Infect Dis. 2004. PMID: 15181574
-
Extensive oral shedding of human herpesvirus 8 in a renal allograft recipient.Oral Microbiol Immunol. 2009 Apr;24(2):109-15. doi: 10.1111/j.1399-302X.2008.00481.x. Oral Microbiol Immunol. 2009. PMID: 19239637
-
Human herpesvirus 8 and oral health care: an update.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Dec;90(6):694-704. doi: 10.1067/moe.2000.110036. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000. PMID: 11113813 Review.
-
Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus.Clin Infect Dis. 2000 Apr;30 Suppl 1:S72-6. doi: 10.1086/313841. Clin Infect Dis. 2000. PMID: 10770915 Review.
Cited by
-
Highly Heterogeneous Kaposi Sarcoma-Associated Herpesvirus Oral Shedding Kinetics Among People With and Without Kaposi Sarcoma and Human Immunodeficiency Virus Coinfection.Open Forum Infect Dis. 2024 Sep 23;11(10):ofae548. doi: 10.1093/ofid/ofae548. eCollection 2024 Oct. Open Forum Infect Dis. 2024. PMID: 39371366 Free PMC article.
-
Factors affecting Kaposi's sarcoma-associated herpesvirus transmission in rural Ugandan households, a longitudinal study.Infect Agent Cancer. 2024 Oct 3;19(1):49. doi: 10.1186/s13027-024-00610-6. Infect Agent Cancer. 2024. PMID: 39363326 Free PMC article.
-
Factors affecting Kaposi's sarcoma-associated herpesvirus transmission in rural Ugandan households, a longitudinal study.Res Sq [Preprint]. 2024 Sep 10:rs.3.rs-4855275. doi: 10.21203/rs.3.rs-4855275/v1. Res Sq. 2024. Update in: Infect Agent Cancer. 2024 Oct 3;19(1):49. doi: 10.1186/s13027-024-00610-6 PMID: 39315255 Free PMC article. Updated. Preprint.
-
Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection in vitro or in vivo.J Virol. 2024 Jun 13;98(6):e0057624. doi: 10.1128/jvi.00576-24. Epub 2024 May 20. J Virol. 2024. PMID: 38767375 Free PMC article.
-
Clinical and Demographic Factors Associated With Kaposi Sarcoma-Associated Herpesvirus Shedding in Saliva or Cervical Secretions in a Cohort of Tanzanian Women.Open Forum Infect Dis. 2024 Mar 19;11(4):ofae161. doi: 10.1093/ofid/ofae161. eCollection 2024 Apr. Open Forum Infect Dis. 2024. PMID: 38654970 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources